7Baggers
 Nurix Therapeutics (NASDAQ:NRIX) Trading Up 6.9% - Time to Buy?  MarketBeat Wed, 12 Nov 2025 20:15:50 GMT
 Nurix Therapeutics appoints Dansey to board of directors  TipRanks Mon, 10 Nov 2025 13:22:28 GMT
 Nurix Therapeutics Appoints Roger Dansey to Board  TipRanks Mon, 10 Nov 2025 12:55:23 GMT
 Nurix Therapeutics appoints former Pfizer oncology executive to board  Investing.com Mon, 10 Nov 2025 12:11:44 GMT
 Nurix targets $250 million stock sale to back pivotal study of leukemia drug  The Business Journals Fri, 07 Nov 2025 12:38:00 GMT
 full technical analysis of nurix therapeutics inc. stock  newser.com Thu, 06 Nov 2025 03:59:46 GMT
 nurix therapeutics announces $250m stock offering  MSN Wed, 05 Nov 2025 14:27:59 GMT
 nurix therapeutics presents data on btk degrader at ash meeting  Traders Union Wed, 05 Nov 2025 01:45:32 GMT
 btig reiterates nurix therapeutics (nrix) buy recommendation  Nasdaq Tue, 04 Nov 2025 12:03:00 GMT
 needham reiterates buy rating for nrix, maintains price target |  GuruFocus Tue, 04 Nov 2025 11:58:42 GMT
 13 Analysts Have This To Say About Nurix Therapeutics  Benzinga Tue, 04 Nov 2025 11:45:14 GMT

Nurix Therapeutics, Inc
(NASDAQ:NRIX) 

NRIX stock logo

Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader with immunomodul...

Founded: 2009
Full Time Employees: 122
CEO: Arthur T. Sands  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends